The stalled Dunkirk pharmaceutical project is moving ahead with a new lease for ImmunityBio and tighter controls.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results